Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Monotherapy vs DAPT in CCS Post-PCI
NCT06509893Phase 4Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in Chronic Coronary Syndrome (CCS), sponsored by Shiraz University of Medical Sciences. Started Aug 2024; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT06509893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06509893.